Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Apr 12;95(5):442-453.
doi: 10.1136/jnnp-2023-331988.

Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis

Enza Leone et al. J Neurol Neurosurg Psychiatry. .

Abstract

Introduction: Management of muscular dystrophies (MD) relies on conservative non-pharmacological treatments, but evidence of their effectiveness is limited and inconclusive.

Objective: To investigate the effectiveness of conservative non-pharmacological interventions for MD physical management.

Methods: This systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and searched Medline, CINHAL, Embase, AMED and Cochrane Central Register of Controlled Trial (inception to August 2022). Effect size (ES) and 95% Confidence Interval (CI) quantified treatment effect.

Results: Of 31,285 identified articles, 39 studies (957 participants), mostly at high risk of bias, were included. For children with Duchenne muscular dystrophy (DMD), trunk-oriented strength exercises and usual care were more effective than usual care alone in improving distal upper-limb function, sitting and dynamic reaching balance (ES range: 0.87 to 2.29). For adults with Facioscapulohumeral dystrophy (FSHD), vibratory proprioceptive assistance and neuromuscular electrical stimulation respectively improved maximum voluntary isometric contraction and reduced pain intensity (ES range: 1.58 to 2.33). For adults with FSHD, Limb-girdle muscular dystrophy (LGMD) and Becker muscular dystrophy (BMD), strength-training improved dynamic balance (sit-to-stand ability) and self-perceived physical condition (ES range: 0.83 to 1.00). A multicomponent programme improved perceived exertion rate and gait in adults with Myotonic dystrophy type 1 (DM1) (ES range: 0.92 to 3.83).

Conclusions: Low-quality evidence suggests that strength training, with or without other exercise interventions, may improve perceived exertion, distal upper limb function, static and dynamic balance, gait and well-being in MD. Although more robust and larger studies are needed, current evidence supports the inclusion of strength training in MD treatment, as it was found to be safe.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart of the study selection process. CBT, Cognitive Behavioural Therapy.
Figure 2
Figure 2
Risk of bias summary for randomised controlled trials only.
Figure 3
Figure 3
Sunburst chart of the characteristics of the included studies. AFO, Ankle Foot Orthosis; BMD, Becker Muscular Dystrophy; CBT, Cognitive Behavioural Therapy; CMD, Congenital Myotonic Dystrophy; DM1, Myotonic Dystrophy type 1; DM2, Myotonic Dystrophy type 2; DMD, Duchenne Muscular Dystrophy; FES, Functional Electrical Stimulation; FO; Foot Orthosis; FSHD, Facioscapulohumeral Dystrophy; HVPGS, High Voltage Pulsed Galvanic Stimulation; KAFO, Knee Ankle Foot Orthosis; LGMD, Limb Girdle Muscular Dystrophy; LGMD2l, Limb Girdle Muscular Dystrophy type 2l; MD, Muscular Dystrophy; NMES, Neuromuscular Electrical Stimulation; VPA, Vibratory Proprioceptive Assistance; WBVT, Whole-Body Vibration Training.
Figure 4
Figure 4
Scatter plots of the effect sizes of the included conservative non-pharmacological interventions. A&P, Activity and Participation; AFO/FO, Ankle Foot Orthosis/Foot Orthosis; AROM, Active Range of Motion; BF, Body Function; BMD, Becker Muscular Dystrophy; BS, Body Structure; CBT, Cognitive Behavioural Therapy; CMD, Congenital Muscular Dystrophy; DM1, Myotonic Dystrophy type 1; DM2, Myotonic Dystrophy type 2; DMD, Duchenne Muscular Dystrophy; ES, Effect Size; FES, Functional Electrical Stimulation; FSHD, Facioscapulohumeral Muscular Dystrophy; HPVGS, High Volt Pulsed Galvanic Stimulator; KAFO, Knee Ankle Foot Orthosis; LGMD, Limb-Girdle Muscular Dystrophy; MD, Muscular Dystrophy; NMES, Neuromuscular Electrical Stimulation; PROM, Passive Range Of Motion; QoL, Quality of Life; VPA, Vibratory Proprioceptive Assistance; WBVT, Whole-Body Vibration Training.
Figure 5
Figure 5
Forest plot of the significant effect sizes in the included studies. ES, Effect Size; MVIC, Maximum Voluntary Isometric Contraction; NMES, Neuromuscular Electrical Stimulation; PSPP-R, Physical Self-Perception Profile Revised; PUL, Performance of Upper Limb; RPE, Rating of Perceived Exertion; STS, Sit To Stand; TCMS, Trunk Control Measurement Scale; VAS, Visual Analogue Scale; VPA, Vibratory Proprioceptive Assistance.

References

    1. Theadom A, Rodrigues M, Roxburgh R, et al. . Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 2014;43:259–68. 10.1159/000369343 - DOI - PubMed
    1. Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet 2019;394:2025–38. 10.1016/S0140-6736(19)32910-1 - DOI - PubMed
    1. Lovering RM, Porter NC, Bloch RJ. The muscular Dystrophies: from genes to therapies. Phys Ther 2005;85:1372–88. 10.1093/ptj/85.12.1372 - DOI - PMC - PubMed
    1. Mercuri E, Muntoni F. Muscular dystrophies. Lancet 2013;381:845–60. 10.1016/S0140-6736(12)61897-2 - DOI - PubMed
    1. Verhaert D, Richards K, Rafael-Fortney JA, et al. . Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 2011;4:67–76. 10.1161/CIRCIMAGING.110.960740 - DOI - PMC - PubMed

Publication types

MeSH terms